
About Aark Pharmaceuticals India Private Limited
Data last updated:
Aark Pharmaceuticals India Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 23 November 2013 and has been in existence for over 13 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24100DL2013PTC260660.
The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹7.5 Lakh. It is led by directors Sanjeev Kansal and Geetika Kansal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at S – 14 Green Park Extension First Floor, New Delhi, Delhi, India – 110016.
The company is associated with 1 brand: Aark Pharma.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website aarkpharma.com.
Company details
Contact details
Aark Pharmaceuticals India Private Limited's registered office is in New Delhi, Delhi. Its website is aarkpharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressS – 14 Green Park Extension First Floor, New Delhi, Delhi, India – 110016
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Aark Pharmaceuticals India Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Aark Pharmaceuticals India operates one associated brand: Aark Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Distributes generic pharmaceuticals to hospitals, governments, and patients worldwide. | aarkpharma.com |
Financials of Aark Pharmaceuticals India Private Limited
FY 2025 filings availableFinancial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | |||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | |||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Aark Pharmaceuticals India Private Limited, buy the company report.
Board of directors of Aark Pharmaceuticals India Private Limited
Aark Pharmaceuticals India has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sanjeev Kansal Also directs: Aark Pharmaceuticals Private Limited | Director | 23 Nov 2013 | 12 Years 11 Months | Current |
| Geetika Kansal Also directs: Aark Pharmaceuticals Private Limited | Director | 23 Nov 2013 | 12 Years 11 Months | Current |
Auditor
Aark Pharmaceuticals India Private Limited is audited by NITIN MITTAL AND CO. for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| NITIN MITTAL AND CO. | FY 2024 | 017642N |
Shareholding
The shareholding of Aark Pharmaceuticals India Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Aark Pharmaceuticals India Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Aark Pharmaceuticals India Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Aark Pharmaceuticals India Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Aark Pharmaceuticals India Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Aark Pharmaceuticals India Private Limited has 3 board changes on record since 2013: 2 appointments and 1 cessation. The latest: Anshu Kansal ceased to be Director on 12 Aug 2014.
Frequently asked questions
Aark Pharmaceuticals India is an active private limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 23 November 2013 (13+ years old) and is registered under CIN U24100DL2013PTC260660.
Aark Pharmaceuticals India has 2 current directors:
- Sanjeev Kansal - Director
- Geetika Kansal - Director
The latest financial statements of Aark Pharmaceuticals India on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Aark Pharmaceuticals India is U24100DL2013PTC260660. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Aark Pharmaceuticals India was incorporated on 23 November 2013, making it 13+ years old. It is registered with the Registrar of Companies, Delhi.
Anshu Kansal ceased to be Director on 12 Aug 2014. Geetika Kansal was appointed as Director on 23 Nov 2013. Sanjeev Kansal was appointed as Director on 23 Nov 2013.
Aark Pharmaceuticals India can be reached through the website aarkpharma.com. Its registered office is in New Delhi, Delhi, India.
The registered office of Aark Pharmaceuticals India is at S – 14 Green Park Extension First Floor, New Delhi, Delhi, India – 110016.
Aark Pharmaceuticals India operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
The compliance status of Aark Pharmaceuticals India is compliant as of 02 July 2026. The company is actively filing with the Registrar of Companies.

